CNO Insider: 4,420-Share Option Exercise and 08/2025 10b5-1 Sales
Rhea-AI Filing Summary
Jeanne L. Linnenbringer, Chief Operations Officer of CNO Financial Group (CNO), exercised stock options and sold common stock under a 10b5-1 plan. On 08/13/2025 she exercised 4,420 stock options with a $21.06 exercise price, acquiring 4,420 shares. Those shares and additional holdings were sold under a Rule 10b5-1 trading plan adopted May 5, 2025, with reported sales on 08/13/2025, 08/14/2025 and 08/15/2025 at weighted average prices of about $37.96, $37.9794 and $37.8495 respectively. Reported beneficial ownership fell from 45,583 shares after the option exercise to 30,844 shares after the sales. The filing notes vesting of the options (half vested 02/23/2019 and half 02/23/2020).
Positive
- Use of a Rule 10b5-1 trading plan (adopted May 5, 2025) provides procedural transparency for the sales
- Exercise of options at $21.06 followed by sales near $37.9 indicates capture of intrinsic value from vested options
Negative
- Reported beneficial ownership declined materially from 45,583 shares after the exercise to 30,844 shares after the sales
- Significant share sales over consecutive days (08/13/2025–08/15/2025) reduced insider holdings, which may be viewed negatively by some investors
Insights
TL;DR: Routine option exercise followed by preplanned 10b5-1 sales; standard insider liquidity activity, not a regulatory red flag on its face.
The filing documents an option exercise at a $21.06 strike and subsequent sales executed under a 10b5-1 plan adopted May 5, 2025. Use of a 10b5-1 plan establishes an affirmative defense for the sales, reducing insider-trading concern assuming plan compliance. The disclosure of weighted average sale prices and the reduction in reported beneficial ownership provide transparency for investors and regulators.
TL;DR: Insider realized value by exercising low-strike options and selling at materially higher market prices; ownership declined materially.
The reporting person exercised 4,420 options with a $21.06 exercise price and sold shares at weighted averages near $37.9 per share across three days, implying a realized spread versus strike for those shares. The filing quantifies the sequential decrease in beneficial ownership from 45,583 to 30,844 shares. Transaction details and price ranges are disclosed, aiding assessment of insider liquidity but not providing forward guidance on company operations.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 3,457 | $37.8495 | $131K |
| Sale | Common Stock | 4,862 | $37.9794 | $185K |
| Exercise | Stock Options | 4,420 | $0.00 | -- |
| Exercise | Common Stock | 4,420 | $21.06 | $93K |
| Sale | Common Stock | 4,420 | $37.9599 | $168K |
| Sale | Common Stock | 2,000 | $37.9599 | $76K |
Footnotes (1)
- Shares sold pursuant to a Rule 10b5-1 trading plan adopted on May 5, 2025. Reflects the weighted average sale price. Shares were sold at prices ranging from $37.82 per share to $38.17 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer. Reflects the weighted average sale price. Shares were sold at prices ranging from $37.795 per share to $38.17 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer. Reflects the weighted average sale price. Shares were sold at prices ranging from $37.68 per share to $38.24 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer. One-half of the stock options vested on February 23, 2019, and one-half vested on February 23, 2020.
